Skip to main navigation Skip to search Skip to main content

BRCA1 and BRCA2 carriers with breast, ovarian and prostate cancer demonstrate a different pattern of metastatic disease compared with non-carriers: results from a rapid autopsy programme

  • Heather Thorne*
  • , Lisa Devereux
  • , Jason Li
  • , Kathryn Alsop
  • , Liz Christie
  • , Courtney T. van Geelen
  • , Nikki Burdett
  • , Kathleen I. Pishas
  • , Noel Woodford
  • , Jodie Leditschke
  • , Mohamed H.M.A. Izzath
  • , Kate Strachan
  • , Gregory Young
  • , Rufaro D. Jaravaza
  • , Mohammed S. Madadin
  • , Melanie Archer
  • , Joanna Glengarry
  • , Linda Iles
  • , Ajith Rathnaweera
  • , Clare Hampson
  • Khamis Almazrooei, Michael Burke, Pradeep Bandara, David Ranson, Essa Saeedi, Orla McNally, Linda Mileshkin, Anne Hamilton, Sumitra Ananda, George Au-Yeung, Yoland Antill, Shahneen Sandhu, Peter Savas, Prudence A. Francis, Stephen Luen, Sherene Loi, Ross Jennens, Clare Scott, Kate Moodie, Margaret Cummings, Andrew Reid, Amy Mc Cart Reed, David Bowtell, Sunil R. Lakhani, Stephen Fox
*Corresponding author for this work
  • University of Melbourne
  • Peter Maccallum Cancer Centre
  • Victorian Institute of Forensic Medicine
  • Monash University
  • Stellenbosch University
  • Base Hospital Dambulla
  • Base Hospital Puttlam
  • Abu Dhabi Police
  • Royal Women's Hospital
  • Cabrini Health
  • Peninsula Health
  • Walter and Eliza Hall Institute of Medical Research
  • Royal Brisbane and Women's Hospital
  • State-Wide Forensic Medical Services
  • University of Tasmania
  • University of Queensland

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'BRCA1 and BRCA2 carriers with breast, ovarian and prostate cancer demonstrate a different pattern of metastatic disease compared with non-carriers: results from a rapid autopsy programme'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Biochemistry, Genetics and Molecular Biology